Bruton tyrosine kinase inhibitors in B-cell lymphoma: beyond the antitumour effect
Bruton tyrosine kinase inhibitors in B-cell lymphoma: beyond the antitumour effect
About this item
Full title
Author / Creator
Wang, Haoran , Guo, Hao , Yang, Jingyi , Liu, Yanyan , Liu, Xingchen , Zhang, Qing and Zhou, Keshu
Publisher
London: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Targeting B-cell receptor signalling using Bruton tyrosine kinase (BTK) inhibitors (BTKis) has become a highly successful treatment modality for B-cell malignancies, especially for chronic lymphocytic leukaemia. However, long-term administration of BTKis can be complicated by adverse on- and/or off-target effects in particular cell types. BTK is wi...
Alternative Titles
Full title
Bruton tyrosine kinase inhibitors in B-cell lymphoma: beyond the antitumour effect
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_acb81b9aa98f43a2b2bda0132c38112a
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_acb81b9aa98f43a2b2bda0132c38112a
Other Identifiers
ISSN
2162-3619
E-ISSN
2162-3619
DOI
10.1186/s40164-022-00315-9
